C4X DiscoveryDrug developmentC4X Discovery bags milestone for IL-17A blocker from SanofiC4X Discovery Holdings Ltd has received a €8m milestone payment from the French pharmaceutical company Sanofi for its preclinical IL-17A inhibitor. This payment is based on a licence agreement from … more ➔
Adobe Stock.com - BoontharikaGenetic engineeringNew way to target mitochondrial diseasesPharmacologists at the University of Göttingen, Germany, have reported a simple way to target and silence individual mitochondrial mRNAs in vivo. more ➔
SLASSLAS/AwardsBiopharma transformation: leading drug discovery start-ups of 2025British company Wildcat Laboratory Solutions Ltd and Hamburg-based mo:re GmbH have received the New Product Award from the Society for Laboratory Automation and Screening (SLAS) in recognition of new … more ➔
TLMSLAS/Drug DiscoveryCountdown to SLAS Europe: ThirdLaw Molecular Inc.Organised by the Society for Laboratory Automation and Screening (SLAS), SLAS Europe currently is taking place in Hamburg from 20–22 May. As part of a special series, European Biotechnology Magazine … more ➔
BioNTechR&DBioNTech Secures £129m UK BackingBioNTech is set to open a research centre for cancer therapy in the United Kingdom, much to the delight of the British government, which is helping pave the way with a substantial financial boost. more ➔
LifeTaq Analytics GmbHSLAS/3D Cell CultureCountdown to SLAS Europe: LifeTaq Analytics GmbHOrganized by the Society for Laboratory Automation and Screening (SLAS), the premier automation conference in Europe, the SLAS Europe 2025 (20-22. May 2025), will showcase the latest technologies and … more ➔
Image by storyset on FreepikDementiaSV Health Raises US$269m for Dementia Start-upsBritish investment firm SV Health Investors has secured US$269m for its second fund, Dementia Discovery Fund, or DDF-2. The capital will be used to invest in companies developing or enabling novel therapeutics … more ➔
Adobe stock_DMHFinancingMassalia Therapeutics kicks off with seed financingFrench biotech firm Massalia Therapeutics SA has been launched, backed by seed funding from Landmark Bioventures, the company founders and their network. The company claims to have an IND-ready, first-in-class … more ➔
ImecDiagosticsIngestible biosensor marks future of medicineBelgian Imec researchers have presented a prototype of an ingestible sensor for long-term gut health monitoring that is able to measure acidifidation that is linked to gut inflammation. more ➔
Instromeda LtdSLAS/Lab automationCountdown to SLAS Europe: Instromeda LtdWith one week remaining before the opening of SLAS Europe 2025—the continent’s largest event dedicated to laboratory automation and drug screening—preparations are nearing completion. The conference, … more ➔
C4X Discovery
Adobe Stock.com - Boontharika
SLAS
TLM
BioNTech
LifeTaq Analytics GmbH
Image by storyset on Freepik
Adobe stock_DMH
Imec
Instromeda Ltd